Cardiff Oncology, Inc.CRDFNASDAQ
Loading
SG&A Expenses Over TimeContracting
Percentile Rank50
3Y CAGR-6.1%
5Y CAGR+5.8%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
-6.1%/yr
vs +13.3%/yr prior
5Y CAGR
+5.8%/yr
Recent deceleration
Acceleration
-19.4pp
Decelerating
Percentile
P50
Within normal range
vs 5Y Ago
1.3x
Solid growth
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $10.91M | -12.6% |
| 2024 | $12.48M | -4.3% |
| 2023 | $13.04M | -1.0% |
| 2022 | $13.18M | +11.3% |
| 2021 | $11.84M | +44.1% |
| 2020 | $8.22M | +42.6% |
| 2019 | $5.76M | -28.0% |
| 2018 | $8.01M | -43.7% |
| 2017 | $14.23M | -38.1% |
| 2016 | $23.00M | - |